These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 24833688)

  • 1. General practitioners' use of absolute risk versus individual risk factors in cardiovascular disease prevention: an experimental study.
    Jansen J; Bonner C; McKinn S; Irwig L; Glasziou P; Doust J; Teixeira-Pinto A; Hayen A; Turner R; McCaffery K
    BMJ Open; 2014 May; 4(5):e004812. PubMed ID: 24833688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors influencing general practitioners' decisions about cardiovascular disease risk reassessment: findings from experimental and interview studies.
    McKinn S; Bonner C; Jansen J; Teixeira-Pinto A; So M; Irwig L; Doust J; Glasziou P; McCaffery K
    BMC Fam Pract; 2016 Aug; 17():107. PubMed ID: 27495325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular risk perception and evidence--practice gaps in Australian general practice (the AusHEART study).
    Heeley EL; Peiris DP; Patel AA; Cass A; Weekes A; Morgan C; Anderson CS; Chalmers JP
    Med J Aust; 2010 Mar; 192(5):254-9. PubMed ID: 20201758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Australian general practitioners initiate statin therapy primarily on the basis of lipid levels; New Zealand general practitioners use absolute risk.
    Schilling C; Knight J; Mortimer D; Petrie D; Clarke P; Chalmers J; Kerr A; Jackson R
    Health Policy; 2017 Dec; 121(12):1233-1239. PubMed ID: 29042060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gaps in cardiovascular disease risk management in Australian general practice.
    Webster RJ; Heeley EL; Peiris DP; Bayram C; Cass A; Patel AA
    Med J Aust; 2009 Sep; 191(6):324-9. PubMed ID: 19769555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implementing cardiovascular disease prevention guidelines to translate evidence-based medicine and shared decision making into general practice: theory-based intervention development, qualitative piloting and quantitative feasibility.
    Bonner C; Fajardo MA; Doust J; McCaffery K; Trevena L
    Implement Sci; 2019 Aug; 14(1):86. PubMed ID: 31466526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mobile phone-based interventions for improving adherence to medication prescribed for the primary prevention of cardiovascular disease in adults.
    Palmer MJ; Barnard S; Perel P; Free C
    Cochrane Database Syst Rev; 2018 Jun; 6(6):CD012675. PubMed ID: 29932455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mobile phone-based interventions for improving adherence to medication prescribed for the primary prevention of cardiovascular disease in adults.
    Palmer MJ; Machiyama K; Woodd S; Gubijev A; Barnard S; Russell S; Perel P; Free C
    Cochrane Database Syst Rev; 2021 Mar; 3(3):CD012675. PubMed ID: 33769555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Burden of cardiovascular disease across 29 countries and GPs' decision to treat hypertension in oldest-old.
    Streit S; Gussekloo J; Burman RA; Collins C; Kitanovska BG; Gintere S; Gómez Bravo R; Hoffmann K; Iftode C; Johansen KL; Kerse N; Koskela TH; Peštić SK; Kurpas D; Mallen CD; Maisonneuve H; Merlo C; Mueller Y; Muth C; Ornelas RH; Šter MP; Petrazzuoli F; Rosemann T; Sattler M; Švadlenková Z; Tatsioni A; Thulesius H; Tkachenko V; Torzsa P; Tsopra R; Tuz C; Verschoor M; Viegas RPA; Vinker S; de Waal MWM; Zeller A; Rodondi N; Poortvliet RKE
    Scand J Prim Health Care; 2018 Mar; 36(1):89-98. PubMed ID: 29366388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Absolute risk of cardiovascular disease events, and blood pressure- and lipid-lowering therapy in Australia.
    Banks E; Crouch SR; Korda RJ; Stavreski B; Page K; Thurber KA; Grenfell R
    Med J Aust; 2016 May; 204(8):320. PubMed ID: 27125809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Using Classification and Regression Trees (CART) to Identify Prescribing Thresholds for Cardiovascular Disease.
    Schilling C; Mortimer D; Dalziel K; Heeley E; Chalmers J; Clarke P
    Pharmacoeconomics; 2016 Feb; 34(2):195-205. PubMed ID: 26578402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patient factors influencing the prescribing of lipid lowering drugs for primary prevention of cardiovascular disease in UK general practice: a national retrospective cohort study.
    Wu J; Zhu S; Yao GL; Mohammed MA; Marshall T
    PLoS One; 2013; 8(7):e67611. PubMed ID: 23922649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High adherence to recommended diabetes follow-up procedures by general practitioners is associated with lower estimated cardiovascular risk.
    Nøkleby K; Berg TJ; Mdala I; Buhl ES; Claudi T; Cooper JG; Løvaas KF; Sandberg S; Jenum AK
    Diabet Med; 2021 Aug; 38(8):e14586. PubMed ID: 33876447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of chance variability in blood pressure readings on the decision making of general practitioners: an internet-based case vignette study.
    Mohammed MA; Marshall T; Gill P
    PLoS One; 2012; 7(11):e46556. PubMed ID: 23133591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patient and other factors influencing the prescribing of cardiovascular prevention therapy in the general practice setting with and without nurse assessment.
    Mohammed MA; El Sayed C; Marshall T
    Med Decis Making; 2012; 32(3):498-506. PubMed ID: 22357626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estimated cardiovascular relative risk reduction from fixed-dose combination pill (polypill) treatment in a wide range of patients with a moderate risk of cardiovascular disease.
    Lafeber M; Webster R; Visseren FLj; Bots ML; Grobbee DE; Spiering W; Rodgers A;
    Eur J Prev Cardiol; 2016 Aug; 23(12):1289-97. PubMed ID: 26743587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vegan dietary pattern for the primary and secondary prevention of cardiovascular diseases.
    Rees K; Al-Khudairy L; Takeda A; Stranges S
    Cochrane Database Syst Rev; 2021 Feb; 2(2):CD013501. PubMed ID: 33629376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk scoring for the primary prevention of cardiovascular disease.
    Karmali KN; Persell SD; Perel P; Lloyd-Jones DM; Berendsen MA; Huffman MD
    Cochrane Database Syst Rev; 2017 Mar; 3(3):CD006887. PubMed ID: 28290160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of cardiovascular disease risk factors, assessment and management in men and women, including consideration of absolute risk: a nationally representative cross-sectional study.
    Banks E; Welsh J; Joshy G; Martin M; Paige E; Korda RJ
    BMJ Open; 2020 Dec; 10(12):e038761. PubMed ID: 33371018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management outcomes of patients with type 2 diabetes: targeting the 10-year absolute risk of coronary heart disease.
    Yong TY; Phillipov G; Phillips PJ
    Med J Aust; 2007 Jun; 186(12):622-4. PubMed ID: 17576176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.